Lv52
970 积分 2025-03-11 加入
Nonneurological aspects of the endocannabinoid system: Nonalcoholic fatty liver disease
8小时前
已完结
The Effect of CB1 Antagonism on Hepatic Oxidative/Nitrosative Stress and Inflammation in Nonalcoholic Fatty Liver Disease
20小时前
已完结
Components of the endocannabinoid system: Hepatic expression levels of the cannabinoid receptors and microRNAs
22小时前
已完结
Serum anandamide level as a potential indicator for nonalcoholic fatty liver disease severity
22小时前
已完结
皖公网安备34019202002308
